Bloomage BioTechnology
VC Fund
Beijing, China
Bloomage BioTechnology is a VC fund in Beijing focused on Biotechnology and Robotics. Bloomage BioTechnology (the “Company”, collectively referred to as the “Group” together with its subsidiaries), founded on 3rd April, 2006 in the Cayman Islands, is an International Group dedicated to develop in the field of biomedicine. Its core subsidiary is a manufacturer and distributor of sodium hyaluronic acid (referred to as “HA”) andfocuses mainly on the development, manufacture and sale of various HA raw materials and end products. The Group has been listed on the Main Board of the Stock Exchange of Hong Kong with the stock code 00963.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Bloomage BioTechnology invests in
Stages Bloomage BioTechnology invests in
Countries Bloomage BioTechnology invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Jin Xuekun
|
|||
|
Liang Shuang
|
|||
Investment Focus
Industry
- Biotechnology 2 (50%)
- Robotics 1 (25%)
- Biopharma 1 (25%)
- Manufacturing 1 (25%)
- Medical Device 1 (25%)
Stage
- Series A 2 (50%)
- Seed 1 (25%)
- Post-IPO Equity 1 (25%)
Country
- China 3 (75%)
- United States 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jin Xuekun
Chief Executive Officer & Executive Director
|
Chief Executive Officer & Executive Director | Total investments: 1 | Find email | |
|
Liang Shuang
Head of Investment
|
Head of Investment | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Synthetic Era
|
Synthera was established through the transformation of research achievements from Tsinghua University and has been continuously delivering technological advancements.Aligning with China's Carbon Peak and Neutrality goals, Synthera focuses on high-value enzyme preparations through premium, specialized, and customized product strategies.Leveraging our innovative core technologies, industrial-scale capabilities, and efficient operations, we deliver competitive biocatalytic solutions that enhance quality of life. | Seed / Mar 27, 2026 | |
Sirnaomics
|
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology. | $17.7M / Post-IPO Equity / Sep 07, 2025 | |
AI² Robotics
|
AI² Robotics is an embodied intelligent robot company that offers research and development of general intelligent embodied terminals. | $14M / Series A / Sep 01, 2025 | |
Shanhai Innovation
|
Shine+ is a diversified high-tech biological development company. | $29.9M / Series A / Jun 24, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bloomage BioTechnology invest in?
Bloomage BioTechnology invests primarily in Biotechnology, Robotics and Biopharma startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Bloomage BioTechnology?
Public channels for Bloomage BioTechnology include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Bloomage BioTechnology?
The team at Bloomage BioTechnology includes Jin Xuekun (Chief Executive Officer & Executive Director) and Liang Shuang (Head of Investment). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
